Summit, New Jersey-based Kenvue Inc. (KVUE) is the world's largest pure-play consumer health company. With a market cap of $37.4 billion, the company develops, manufactures, and markets a broad portfolio of over-the-counter (OTC) medicines, skincare, oral care, baby care, and other personal health products that are sold in more than 165 countries.
KVUE stock has declined 11.7% over the past 52 weeks and has grown 14.5% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 16.3% over the past year and risen 8.5% in 2026.